1. Home
  2. MATH vs IOBT Comparison

MATH vs IOBT Comparison

Compare MATH & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • IOBT
  • Stock Information
  • Founded
  • MATH 2015
  • IOBT 2014
  • Country
  • MATH Hong Kong
  • IOBT Denmark
  • Employees
  • MATH N/A
  • IOBT N/A
  • Industry
  • MATH Finance/Investors Services
  • IOBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATH Finance
  • IOBT Health Care
  • Exchange
  • MATH Nasdaq
  • IOBT Nasdaq
  • Market Cap
  • MATH 64.9M
  • IOBT 57.9M
  • IPO Year
  • MATH N/A
  • IOBT 2021
  • Fundamental
  • Price
  • MATH $1.91
  • IOBT $1.00
  • Analyst Decision
  • MATH
  • IOBT Strong Buy
  • Analyst Count
  • MATH 0
  • IOBT 3
  • Target Price
  • MATH N/A
  • IOBT $9.33
  • AVG Volume (30 Days)
  • MATH 99.2K
  • IOBT 220.6K
  • Earning Date
  • MATH 10-31-2024
  • IOBT 05-13-2025
  • Dividend Yield
  • MATH N/A
  • IOBT N/A
  • EPS Growth
  • MATH N/A
  • IOBT N/A
  • EPS
  • MATH 0.17
  • IOBT N/A
  • Revenue
  • MATH $31,399,049.00
  • IOBT N/A
  • Revenue This Year
  • MATH N/A
  • IOBT N/A
  • Revenue Next Year
  • MATH N/A
  • IOBT N/A
  • P/E Ratio
  • MATH $10.19
  • IOBT N/A
  • Revenue Growth
  • MATH 291.58
  • IOBT N/A
  • 52 Week Low
  • MATH $0.80
  • IOBT $0.66
  • 52 Week High
  • MATH $2.78
  • IOBT $1.79
  • Technical
  • Relative Strength Index (RSI)
  • MATH 52.13
  • IOBT 49.67
  • Support Level
  • MATH $1.75
  • IOBT $0.90
  • Resistance Level
  • MATH $2.10
  • IOBT $1.24
  • Average True Range (ATR)
  • MATH 0.16
  • IOBT 0.10
  • MACD
  • MATH -0.01
  • IOBT 0.01
  • Stochastic Oscillator
  • MATH 57.78
  • IOBT 26.71

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: